151 related articles for article (PubMed ID: 29445299)
1. Choosing wisely after publication of level I evidence in breast cancer radiotherapy.
Niska JR; Keole SR; Pockaj BA; Halyard MY; Patel SH; Northfelt DW; Gray RJ; Wasif N; Vargas CE; Wong WW
Breast Cancer (Dove Med Press); 2018; 10():31-37. PubMed ID: 29445299
[TBL] [Abstract][Full Text] [Related]
2. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer.
Suh WW; Pierce LJ; Vicini FA; Hayman JA
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):790-6. PubMed ID: 15936561
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated radiation in older women with breast cancer.
Wallace AS; Keene KS; Williams CP; Jackson BE; Pisu M; Rocque GB
Breast J; 2019 Nov; 25(6):1206-1213. PubMed ID: 31359556
[TBL] [Abstract][Full Text] [Related]
4. Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials.
Jagsi R; Falchook AD; Hendrix LH; Curry H; Chen RC
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1001-9. PubMed ID: 25539365
[TBL] [Abstract][Full Text] [Related]
5. Cost Implications of an Evidence-Based Approach to Radiation Treatment After Lumpectomy for Early-Stage Breast Cancer.
Greenup RA; Blitzblau RC; Houck KL; Sosa JA; Horton J; Peppercorn JM; Taghian AG; Smith BL; Hwang ES
J Oncol Pract; 2017 Apr; 13(4):e283-e290. PubMed ID: 28291382
[TBL] [Abstract][Full Text] [Related]
6. Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries.
Halasz LM; Patel SA; McDougall JA; Fedorenko C; Sun Q; Goulart BHL; Roth JA
PLoS One; 2019; 14(9):e0222904. PubMed ID: 31568536
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
Hummel S; Simpson EL; Hemingway P; Stevenson MD; Rees A
Health Technol Assess; 2010 Oct; 14(47):1-108, iii-iv. PubMed ID: 21029717
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial.
Viani GA; Viana BS; Martin JE; Rossi BT; Zuliani G; Stefano EJ
Cancer; 2016 Jul; 122(13):2004-11. PubMed ID: 27028170
[TBL] [Abstract][Full Text] [Related]
9. A cost comparison analysis of adjuvant radiation therapy techniques after breast-conserving surgery.
Lanni T; Keisch M; Shah C; Wobb J; Kestin L; Vicini F
Breast J; 2013; 19(2):162-7. PubMed ID: 23294184
[TBL] [Abstract][Full Text] [Related]
10. Clinical Effectiveness of an Adaptive Treatment Planning Algorithm for Intensity Modulated Radiation Therapy Versus 3D Conformal Radiation Therapy for Node-Positive Breast Cancer Patients Undergoing Regional Nodal Irradiation/Postmastectomy Radiation Therapy.
Bazan JG; Healy E; Beyer S; Kuhn K; DiCostanzo D; Smith TL; Jhawar S; White JR
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1159-1171. PubMed ID: 32711036
[TBL] [Abstract][Full Text] [Related]
11. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
[TBL] [Abstract][Full Text] [Related]
12. Abbreviated course of radiotherapy (RT) for breast cancer.
Schoenfeld JD; Harris JR
Breast; 2011 Oct; 20 Suppl 3():S116-27. PubMed ID: 22015277
[TBL] [Abstract][Full Text] [Related]
13. Temporal impact of the publication of guidelines and randomised evidence on the adoption of hypofractionated whole breast radiotherapy for early-stage breast cancer.
Jung KYK; Shadbolt B; Rezo A
J Med Imaging Radiat Oncol; 2019 Aug; 63(4):530-537. PubMed ID: 31087640
[TBL] [Abstract][Full Text] [Related]
14. Cost comparison of radiation treatment options after lumpectomy for breast cancer.
Greenup RA; Camp MS; Taghian AG; Buckley J; Coopey SB; Gadd M; Hughes K; Specht M; Smith BL
Ann Surg Oncol; 2012 Oct; 19(10):3275-81. PubMed ID: 22851048
[TBL] [Abstract][Full Text] [Related]
15. Association of Utilization Management Policy With Uptake of Hypofractionated Radiotherapy Among Patients With Early-Stage Breast Cancer.
Parikh RB; Fishman E; Chi W; Zimmerman RP; Gupta A; Barron JJ; Sylwestrzak G; Bekelman JE
JAMA Oncol; 2020 Jun; 6(6):839-846. PubMed ID: 32297905
[TBL] [Abstract][Full Text] [Related]
16. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
[TBL] [Abstract][Full Text] [Related]
17. Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ.
Williamson D; Dinniwell R; Fung S; Pintilie M; Done SJ; Fyles AW
Radiother Oncol; 2010 Jun; 95(3):317-20. PubMed ID: 20400190
[TBL] [Abstract][Full Text] [Related]
18. Planning comparison of intensity modulated radiation therapy delivered with 2 tangential fields versus 3-dimensional conformal radiotherapy for cardiac sparing in women with left-sided breast cancer.
Taunk NK; Prosnitz RG
Pract Radiat Oncol; 2012; 2(4):248-256. PubMed ID: 24674160
[TBL] [Abstract][Full Text] [Related]
19. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy using two static ports of tomotherapy for breast cancer after conservative surgery: dosimetric comparison with other treatment methods and 3-year clinical results.
Nagai A; Shibamoto Y; Yoshida M; Inoda K; Kikuchi Y
J Radiat Res; 2017 Jul; 58(4):529-536. PubMed ID: 28339844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
